Patents-Review.com
ClassID:

169363 ⎘

G01N33/9473 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors Anticonvulsants, e.g. phenobarbitol, phenytoin

Recent Application in this class:
#1
20250003929
2025-01-02

HIGH THROUGHPUT SCREENING AND QUANTIFICATION FOR TARGET ANALYTES USING ECHO MS AND SINGLE TUBE CALIBRATION

 #2
20240215910
2024-07-04

A METHOD FOR EVALUATING THE PRO-OR ANTI CONVULSIVE PROPERTIES OF TEST COMPOUNDS

 #3
20240192236
2024-06-13

Compounds and Methods for Use in Detecting Gabapentin

 #4
20240174600
2024-05-30

Pregabalin artificial hapten, artificial antigen and preparation method therefor and application thereof

 #5
20230273217
2023-08-31

DERIVATIZATION OF AT LEAST ONE ANALYTE OF INTEREST FOR MASS SPEC MEASUREMENTS IN PATIENT SAMPLES

 #6
20220357331
2022-11-10

Levetiracetam immunoassays

 #7
20220326263
2022-10-13

Compounds and methods for use in detecting gabapentin

 #8
20220308021
2022-09-29

Methods for detecting lacosamide by mass spectrometry

 #9
20220289667
2022-09-15

Pregabalin artificial hapten, artificial antigen and preparation method therefor and application thereof

 #10
20220003793
2022-01-06

Compounds and methods for use in detecting gabapentin

 #11
20200400696
2020-12-24

Compounds and methods for use in detecting gabapentin

 #12
20200340960
2020-10-29

Methods for detecting lacosamide by mass spectrometry

 #13
20200240991
2020-07-30

Levetiracetam immunoassays

 #14
20200116681
2020-04-16

Methods for detecting lacosamide by mass spectrometry

 #15
20190145991
2019-05-16

Compounds and Methods for Use in Detecting Gabapentin

 #16
20180224407
2018-08-09

Methods for detecting lacosamide by mass spectrometry

 #17
20170138970
2017-05-18

Compounds and methods for use in detecting gabapentin

 #18
20170102368
2017-04-13

Methods for detecting lacosamide by mass spectrometry

 #19
20150140575
2015-05-21

Methods for determining ligand binding to a target protein using a thermal shift assay

 #20
20150111778
2015-04-23

BIO-NANO-CHIP FOR ANTICONVULSANT DRUG SALIVARY ASSAY

 #21
20150024456
2015-01-22

Compounds and methods for use in detecting gabapentin

 #22
20140361160
2014-12-11

Methods for detecting lacosamide by mass spectrometry

 #23
20140212989
2014-07-31

PHENYTOIN BIOSENSOR AND METHOD FOR MEASURING CONCENTRATION OF PHENYTOIN

 #24
20140209484
2014-07-31

Valproic acid biosensor and method for measuring concentration of valproic acid

 #25
20140057368
2014-02-27

Methods for determining ligand binding to a target protein using a thermal shift assay

 #26
20130168544
2013-07-04

Methods for detecting lacosamide by mass spectrometry

 #27
20120322089
2012-12-20

Sensitive and generic antibodies and multiple applications

 #28
20120190047
2012-07-26

Levetiracetam immunoassays

 #29
20110306080
2011-12-15

DETERMINATION OF LAMOTRIGINE BY MASS SPECTROMETRY

 #30
20100317024
2010-12-16

Derivatives, reagents, and immunoassay for detecting levetiracetam

 #31
20100209416
2010-08-19

Immunoassays for lamotrigine

 #32
20100173427
2010-07-08

Levetiracetam immunoassays

 #33
20080199887
2008-08-21

Compounds and methods for use in detecting gabapentin

 #34
20080009018
2008-01-10

Immunoassays for topiramate

 #35
20070135514
2007-06-14

Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases

 #36
20060172356
2006-08-03

Immunoassays for lamotrigine

 #37
20060088886
2006-04-27

Topiramate analogs

 #38
20060088885
2006-04-27

Immunoassays for topiramate

 #39
20060024832
2006-02-02

Water-soluble derivatives of lipophilic drugs